The Asia Pacific Electronic Clinical Outcome Assessment Solution Market (eCOA)would witness market growth of 20.6% CAGR during the forecast period (2020-2026).
With an aim to gather patient data in a clinical trial, an eCOA solution is utilized. The global electronic clinical outcome assessment (eCOA) solutions market is anticipated to witness consistent & high growth over the forecast years. Some aspects including a wide consumer base globally, increasing public-private funding for clinical researchers, high regulatory compliance across industrial researchers, growing requirement for enhanced data centralization & collection for early regulatory approval are anticipated to open growth avenues for the eCOA market.
The leading players operating in the market are expected to witness various growth possibilities due to many factors such as increasing number of clinical research around developing economies, rising outsourcing of research activities by pharma companies, and changing preference from manual data interpretation to real-time data analysis. On the flip side, the growth of the eCOA market would be hampered due to the high cost of installation & scarcity of skilled professionals of accurate data interpretation.
The market growth is expected to be driven by some significant aspects including high R&D investments by the pharma giants, increasing demand for clinical trials in developing markets, and a rising number of diseases. Also, the paradigm shift from manual data interpretation to real-time data analysis would also support the growth of the eCOA market.
In addition to it, regulatory bodies are putting a high emphasis on assessing wider properties of patient well-being in order to enhance the overall well-being. Hence, clinical outcome assessments (COAs) are constantly utilized to evaluate the treatments’ influence on several chronic diseases, and in some cases, these have a considerable role in the regulatory approval of drugs. Although, the major restraints for the market growth are the huge cost of implementation & data privacy concerns.
Based on Delivery Mode, the market is segmented into Web-hosted eCOA, Cloud-based eCOA, and Licensed enterprises eCOA. Based on End Use, the market is segmented into Contract Research Organizations (CROs), Hospitals, Academic Institutes, Pharma & Biotech Companies and Medical Device Manufacturers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Pharma & Biotech Companies Market by Country in 2019, thereby, achieving a market value of $17.1 Million by 2026. The Japan market is exhibiting a CAGR of 21.9% during (2020 - 2026). Additionally, The India market is anticipated to witness a CAGR of 22.7% during (2020 - 2026).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Dassault Systemes SE, IQVIA Holdings, Inc., Parexel International Corporation (Pamplona Capital Management), IBM Corporation (Merge Healthcare), Signant Health, ERT Clinical, eClinical Solutions LLC, Castor EDC and Anju Software, Inc. (OmniComm Systems).
Scope of the Study
Market Segments covered in the Report:
By Delivery Mode
• Web-hosted eCOA
• Cloud-based eCOA
• Licensed enterprises eCOA
By End Use
• Contract Research Organizations (CROs)
• Academic Institutes
• Pharma & Biotech Companies
• Medical Device Manufacturers
• South Korea
• Rest of Asia Pacific
• Oracle Corporation
• Dassault Systemes SE
• IQVIA Holdings, Inc.
• Parexel International Corporation (Pamplona Capital Management)
• IBM Corporation (Merge Healthcare)
• Signant Health
• ERT Clinical
• eClinical Solutions LLC
• Castor EDC
• Anju Software, Inc. (OmniComm Systems)
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The Global Electronic Clinical Outcome Assessment Solution Market (eCOA) size is expected to reach $2.4 billion by 2026, rising at a market growth of 19% CAGR during the forecast period. Electronic clinical outcome assessment (eCOA) refers to a system that is capable of measuring mental state, patient symptom, and the prognosis of a disease....
384 pages •
By Global Industry Analysts
• Apr 2021
- The global Label-Free Detection market is projected to reach US$1.3 billion by 2025, driven by growing drug R&D, rising competitive pressure to reduce cost of drug development and the resulting need for cost-effective and efficient screening technologies. Traditional label-based assays are beset with drawbacks...
The Europe microplate readers market is expected to reach US$ 175.96 million by 2027 from US$ 139.69 million in 2019; it is estimated to grow at a CAGR of 3.0% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing incidence of infectious diseases and consistent research in drug discovery activities....
The manufacturing execution system market is expected to grow from USD 11.5 billion in 2021 to USD 17.1 billion by 2026 at a CAGR of 8.3% from 2021 to 2026. A few key factors driving the growth of this market include increasing use of industrial automation in process and discrete industries, increasing IT and OT convergence, and the need for...
The Asia Pacific microplate readers market is expected to reach US$ 152.15 million by 2027 from US$ 110.87 million in 2019; it is estimated to grow at a CAGR of 4.1% from 2020 to 2027. The growth of the market is attributed to the factors such as technological advancements in microplate readers and consistent research in drug discovery activities....
Anesthesia is one of the most essential components for any surgical procedure. It induces temporary unconsciousness and loss of protective reflexes. According to the Centers for Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017, with...
The Middle East and Africa microplate readers market is expected to reach US$ 19.79 million by 2027 from US$ 16.24 million in 2019; it is estimated to grow with a CAGR of 2.6% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing incidence of infectious diseases and consistent research in...
The ePRO, epatient diaries, and eCOA market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.08% during 2020-2028. Increasing demand for electronic health records (EHRs) and rising use of smartphones are fueling the market growth. However, concerns...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.